针对RAB11A-FIP2复合体的片抑制HPIV3,RSV和IAV的复制,作为广泛的抗病毒药物

Yanliang Jiang1, Yongliang Zhao1, Jie Deng1

  • 1State Key Laboratory of Virology and Biosafety, Hubei Provincial Research Center for Basic Biological Sciences, College of Life Sciences, Wuhan University, Wuhan, 430072, China.

Cell & bioscience
|April 21, 2025
PubMed
概括

一种新型的,YT-DRI,针对RAB11A-FIP2复合体,通过破坏病毒核体的运输和组装来抑制呼吸道RNA病毒 (如HPIV3,RSV和IAV) 的复制.